Skip to content

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2025

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2025

The information is for S. enterica culture isolates received during the designated year.

Serotypic name No. tested Sterile site specimens Non-sterile site specimens
Total Ciprofloxacin Ceftriaxone Total Ciprofloxacin Ceftriaxone
R I R I R I R I
Enteritidis 516 117 1% 81% 6% 0% 399 1% 81% 7% 0%
I 4:i:- 358 12 8% 58% 8% 0% 346 1% 52% 12% 0%
London 123 6 0% 50% 0% 0% 117 2% 47% 2% 0%
Rissen 114 6 0% 0% 0% 0% 108 1% 45% 1% 0%
Typhimurium 92 4 0% 50% 0% 0% 88 0% 89% 13% 0%
Goldcoast 60 4 0% 0% 0% 0% 56 5% 25% 9% 0%
Derby 58 4 0% 75% 0% 0% 54 17% 48% 0% 0%
Typhi 11 11 55% 36% 27% 0% 0 - - - -
Others 316 22 5% 50% 18% 0% 294 8% 36% 17% 1%


Remarks:

Multiple strains may have been received from the same patient.